Black Rock Inc. Endo International PLC Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.1 - $0.75 $1.86 Million - $14 Million	-18,633,065 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.3 - $2.74 $5.72 Million - $52.3 Million	-19,071,452 Reduced 50.58%	18,633,065 $8.68 Million
Q1 2022 May 12, 2022	BUY	$2.13 - $3.85 $1.87 Million - $3.38 Million	876,657 Added 2.38%	37,704,517 $87.1 Million
Q4 2021 Feb 10, 2022	BUY	$3.39 - $6.76 $1.36 Million - $2.71 Million	400,654 Added 1.1%	36,827,860 $138 Million
Q3 2021 Nov 09, 2021	SELL	$2.1 - $5.19 $969,945 - $2.4 Million	-461,879 Reduced 1.25%	36,427,206 $118 Million
Q2 2021 Aug 11, 2021	BUY	$4.68 - $7.39 $173 Million - $273 Million	36,889,085 New	36,889,085 $173 Million

Ticker ENDP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 235,143,008
Market Cap $68.8M
Description
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.